NEWS
Sona Nanotech Closes Unbrokered Private Placement Financing for $2.26m in Gross Proceeds
Read Orginal Article Here December 16, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”, “Sona”) a developer of rapid, point-of-care diagnostic tests, is pleased to announce that it has closed its non-brokered private placement...
Motryx announces partnership with Aerocom
Read Original Article Simple and reliable validation of Pneumatic Tube Systems for blood sample integrity monitoring Halifax, Canada, December 2020 – Motryx, provider of blood transport validation and verification services, today announced a partnership with Aerocom,...
NEWS RELEASE – BioNova Announces Swiftsure Innovations as the Winner of the Tenth Annual BioInnovation Challenge (BIC) at BioPort 2020
FOR IMMEDIATE RELEASE November 4, 2020 BioNova Announces Swiftsure Innovations as the Winner of the Tenth Annual BioInnovation Challenge (BIC) at BioPort 2020 Halifax, NS – November 4, 2020 – Today Swiftsure Innovations from Newfoundland was named the winner of...
DeCell Technologies Obtain First Ever in the World Patent Protection
DeCell Technologies has now obtained patents for its novel and innovative prECM™ decellularization technology in the U.S., Canada, and five countries in the E.U. (UK, France, Spain, Germany and Italy). These patents include process protection and for the first time...
Start-Ups Selected for Innovacorp’s Fall 2020 Sprint Program
Read Orginal Article Here Innovacorp received 60 submissions for its latest round of Sprint and, after many hours of reviewing and deliberating, selected nine companies to participate in the program. Congratulations to the start-ups chosen for Innovacorp’s 2020 Sprint...
EVENTS
SOCIAL
Windsor NS & Charlottetown PEI based @BioVectra have safely onboarded over 150 new highly-skilled team members since the onset of the COVID-19 pandemic in 2020 👏. Check out the latest additions to their leadership team. https://t.co/zBfPOu7SyH
🎉Congrats to our members Precision BioLogic Inc., leading developers of #hemostasis diagnostic products, on the launch of their new #Lupus Anticoagulant Test in the U.S.
➡️Learn more:
https://t.co/ESX1ckuEd2 https://t.co/jwg2FjikF7
ABOUT BIONOVA
Our mandate is to:
- LEAD the development of Health and Life Science in Nova Scotia
- ACCELERATE companies and the business ecosystem
- ADVOCATE for the sector and growth of Nova Scotia’s BioEconomy
OUR SECTOR STRENGTHS
Medical Technologies- Digital Health
- Pharmaceuticals & Vaccines
- Natural Health Products
- BioProducts
Medical Technologies
Digital Health
Pharmaceuticals & Vaccines
Natural Health Products
BioProductsPlease visit our Sector Strengths page to learn more.
OUR ACCELERATION INITIATIVES
BioNova aims to accelerate the innovation and productivity of businesses in Nova Scotia’s bioeconomy through our Projects, Programs, Services & Events with the support of our stakeholders and funding partners.